Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF. (Q34733351)

4 August 2017

1 reference

title

Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF. (English)

1 reference

4 August 2017

Ronald G Tilton

1

1 reference

PubMed ID

12112445

4 August 2017

language of work or name

1 reference

1 June 2002

1 reference

Microscopy Research and Technique

4 August 2017

1 reference

4 August 2017

57

1 reference

4 August 2017

390-407

1 reference

4 August 2017

5

1 reference

Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group

4 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Molecular mechanisms of vascular permeability in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Immunocytochemical detection of advanced glycated end products in rat renal tissue as a function of age and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Glycation products and the pathogenesis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Advanced protein glycosylation in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Advanced glycosylation end products in diabetic renal and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart. Near-complete prevention of reperfusion contractile failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Diabetes mellitus: a hypercoagulable state

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

The protective action of pyruvate on recovery of ischemic rat heart: comparison with other oxidizable substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Advanced glycation end products, oxidant stress and vascular lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Endothelin and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Simultaneous measurement of ERK, p38, and JNK MAP kinase cascades in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

The aldose reductase controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

From receptors to stress-activated MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

The role of hyperglycaemia and hyperinsulinaemia in causing vascular dysfunction in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Protein kinase C activation and the development of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Antioxidants, diabetes and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Advanced glycation end products increase retinal vascular endothelial growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Pathogenetic potential of leukocytes in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Regulation of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Diabetes-induced changes in retinal NAD-redox status: pharmacological modulation and implications for pathogenesis of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Vascular filtration function in galactose-fed versus diabetic rats: the role of polyol pathway activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Advanced glycation endproducts stimulate the MAP-kinase pathway in tubulus cell line LLC-PK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Advanced glycation end-products: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Diabetes-induced glomerular dysfunction: links to a more reduced cytosolic ratio of NADH/NAD+.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Mitogen-activated protein kinases as glucose transducers for diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Hyperglycemic pseudohypoxia and diabetic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Reactive oxygen species and vascular signal transduction mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Hypoxic regulation of vascular endothelial growth factor in retinal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Elevation of erythrocyte redox potential linked to galactonate biosynthesis: elimination by Tolrestat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Reactive oxygen species and acute modulation of albumin microvascular leakage in the microcirculation of diabetic rats in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Augmented retinal endothelin-1, endothelin-3, endothelinA and endothelinB gene expression in chronic diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Effect of aldose reductase inhibition on glutathione redox status in erythrocytes of diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Interactions between the sorbitol pathway, non-enzymatic glycation, and diabetic vascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Amelioration of diabetes-like retinal changes in galactose-fed dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Metabolism of fructose-3-phosphate in the diabetic rat lens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Glutathione depletion in the lens of galactosemic and diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Protein kinase C and myocardial biology and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

The missing link: a single unifying mechanism for diabetic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Amyloid beta 2-microglobulin is modified with N epsilon-(carboxymethyl)lysine in dialysis-related amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Aldose reductase inhibitors: therapeutic implications for diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Interaction between osmotic and oxidative stress in diabetic precataractous lens: studies with a sorbitol dehydrogenase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Angiogenic effects of advanced glycation end products of the Maillard reaction on cultured human umbilical cord vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Pericyte degeneration and acellular capillaries are increased in the feet of human diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Recent progress in advanced glycation end products and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Glucose-induced vascular smooth muscle dysfunction: the role of protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

Effects of vascular endothelial growth factor on hemodynamics and cardiac performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJEMT.10092

21 January 2018

Identifiers

DOI

10.1002/JEMT.10092

1 reference

4 August 2017

1 reference

PubMed ID

12112445